ASCO Presses for Inclusion of Older Adults in Research
With more than 60 percent of cancers in the United States occurring in people age 65 and older, the evidence base for treating older adults is sparse.
ASCO recently presented a position statement “Improving the Evidence Base for Treating Older Adults with Cancer.” With more than 60 percent of cancers in the United States occurring in people age 65 and older, the evidence base for treating older adults is sparse because they are underrepresented in clinical trials and trials designed specifically for them are rare. Developed by ASCO’s Cancer Research Committee, the organization call for five over-arching recommendations:
- Use clinical trials to improve the evidence base for treating older adults.
- Leverage research designs and infrastructure to improve the evidence base for treating older adults.
- Increase Food and Drug Administration (FDA) authority to incentivize and require research on older adults with cancer.
- Increase clinicians’ recruitment of older adults with cancer into clinical trials.
- Utilize journal policies to incentivize researchers to consistently report on the age distribution and health risk profiles of research participants.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
